Shanghai Vive

Viva Biotech is a China-based, publicly traded life science services company that provides integrated CRO and CDMO offerings spanning early drug discovery through commercial manufacturing. The company is best known for its structure-based drug discovery platform, with capabilities in X-ray crystallography, Cryo-EM, affinity mass spectrometry, SPR, HDX-MS, AI-assisted computational chemistry, and medicinal chemistry. Beyond fee-for-service work, Viva has built an equity-for-service model and incubator ecosystem that supports early-stage biotech companies while giving it exposure to external innovation. Its operating footprint includes drug discovery operations centered in Shanghai and broader manufacturing capabilities through Langhua Pharmaceutical and related units. For a biotech analyst, Viva is best viewed as a commercial-stage discovery-and-development infrastructure company rather than a therapeutics developer with a proprietary clinical pipeline.